Enjoy the ease of home delivery and continuous support from our provider network
Tirzepatide (Mounjaro, Zepbound) is a peptide-based medication that acts as a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist
We built meal bundles that match
This keeps treatment safe, predictable, and aligned with each patients goals
During the 30-week placebo-controlled period of the study, vomiting occurred in 3%, 16%, and 12% of patients and abdominal pain occurred in 9%, 22%, and 15% of patients treated with placebo, MOUNJARO 5 mg, and 10 mg, respectively
Promueve la prdida de peso en ciertos casos como beneficio asociado